Powered by

Innovative Test Developed by Navigator Genomics for Medical Cannabis & Prescription Drugs

Nov 20, 2018 - PR Newswire

PR Newswire

 Navigator Genomics(TM) (NGT) is the first company to measure and report your personal genetic metabolismandresponses for key cannabinoids utilized in Medical Cannabis (MMJ) simultaneously, with 416 of the most popularly prescribed prescription medications (Rx) taken by the most amount of people. Results include important drug-drug interactions which can reduce or cancel efficacy of MMJ or Rx's, create unwanted side-effects or even adverse reactions. Results help tailor what...